扩散内在脑桥的神经胶质瘤(DIPGs) aggressive and malignant tumors of the brainstem. Stereotactic biopsy can obtain molecular and genetic information for diagnostic and potentially therapeutic purposes. However, there is no consensus on the safety of biopsy or effect on survival. The authors aimed to characterize neurological risk associated with and the effect of stereotactic biopsy on survival among patients with DIPGs.
A systematic review was performed in accordance with PRISMA guidelines to identify all studies examining pediatric patients with DIPG who underwent stereotactic biopsy. The search strategy was deployed in PubMed, Embase, and Scopus. The quality of studies was assessed using the Grading of Recommendations, Assessment, Development and Evaluation system, and risk of bias was evaluated with the Cochrane Risk of Bias in Nonrandomized Studies–of Interventions tool. Bibliographic, demographic, clinical, and outcome data were extracted from studies meeting inclusion criteria.
Of 2634 resultant articles, 13 were included, representing 192 patients undergoing biopsy. The weighted mean age at diagnosis was 7.5 years (range 0.5–17 years). There was an overall neurosurgical complication rate of 13.02% (25/192). The most common neurosurgical complication was cranial nerve palsy (4.2%, 8/192), of which cranial nerve VII was the most common (37.5%, 3/8). The second most common complication was perioperative hemorrhage (3.6%, 7/192), followed by hemiparesis (2.1%, 4/192), speech disorders (1.6%, 3/192) such as dysarthria and dysphasia, and movement disorders (1.0%, 2/192). Hydrocephalus was less commonly reported (0.5%, 1/192), and there were no complications relating to wound infection/dehiscence (0%, 0/192) or CSF leak (0%, 0/192). No mortality was specifically attributed to biopsy. Diagnostic yield of biopsy revealed a weighted mean of 97.4% (range 91%–100%). Of the studies reporting survival data, 37.6% (32/85) of patients died within the study follow-up period (range 2 weeks–48 months). The mean overall survival in patients undergoing biopsy was 9.73 months (SD 0.68, median 10 months, range 6–13 months).
Children with DIPGs undergoing biopsy have mild to moderate rates of neurosurgical complications and no excessive morbidity. With reasonably acceptable surgical risk and high diagnostic yield, stereotactic biopsy of DIPGs can allow for characterization of patient-specific molecular and genetic features that may influence prognosis and the development of future therapeutic strategies.
INCLUDE WHEN CITINGPublished online September 8, 2023; DOI: 10.3171/2023.7.PEDS22462.
DisclosuresThe authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
KebudiR,CakirFB.Management of diffuse pontine gliomas in children: recent developments.Paediatr Drugs.2013;15(5):351–362.
MisuracaKL,有限公司rderoFJ,BecherOJ.Pre-clinical models of diffuse intrinsic pontine glioma.Front Oncol.2015;5(JUL):172.
WarrenKE.Diffuse intrinsic pontine glioma: poised for progress.Front Oncol.2012;2:205.
RennertRC,BrandelMG,斯S,et al.Palliative endoscopic third ventriculostomy for pediatric primary brain tumors: a single-institution case series.J Neurosurg Pediatr.2021;28(4):387–394.
CageTA,SamaghSP,MuellerS,et al.Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children.Childs Nerv Syst.2013;29(8):1313–1319.
GiagnacovoM,AntonelliM,BiassoniV,et al.Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).Childs Nerv Syst.2020;36(4):697–704.
AlbrightAL,PackerRJ,ZimmermanR,RorkeLB,BoyettJ,HammondGD.Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group.开云体育app官方网站下载入口.1993;33(6):1026–1030.
DawesW,MarcusHJ,TisdallM,AquilinaK.Robot-assisted stereotactic brainstem biopsy in children: prospective cohort study.J Robot Surg.2019;13(4):575–579.
JanjuaMB,BanVS,El AhmadiehTY,et al.Diffuse intrinsic pontine gliomas: diagnostic approach and treatment strategies.J Clin Neurosci.2020;72:15–19.
BrozekJL,Canelo-AybarC,AklEA,et al.GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.J Clin Epidemiol.2021;129:138–150.
SterneJA,HernánMA,ReevesBC,et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.BMJ.2016;355:i4919.
CaraiA,MastronuzziA,De BenedictisA,et al.Robot-assisted stereotactic biopsy of diffuse intrinsic pontine glioma: a single-center experience.World Neurosurg.2017;101:584–588.
有限公司caHA,CebulaH,BenmekhbiM,ChenardMP,Entz-WerleN,ProustF.Diffuse intrinsic pontine gliomas in children: interest of robotic frameless assisted biopsy. A technical note.Neurochirurgie.2016;62(6):327–331.
GuptaN,GoumnerovaLC,ManleyP,et al.Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.Neuro Oncol.2018;20(11):1547–1555.
JoudA,StellaI,KleinO.Diffuse infiltrative pontine glioma biopsy in children with neuronavigation, frameless procedure: a single center experience of 10 cases.Neurochirurgie.2020;66(5):345–348.
LabuschagneJ,MutyabaD,NelJ,CasieriC.Use of intra-operative stimulation of brainstem lesion target sites for frameless stereotactic biopsies.Childs Nerv Syst.2021;37(5):1515–1523.
PhiJH,ChungHT,WangKC,RyuSK,KimSK.Transcerebellar biopsy of diffuse pontine gliomas in children: a technical note.Childs Nerv Syst.2013;29(3):489–493.
PincusDW,RichterEO,YachnisAT,BennettJ,BhattiMT,SmithA.Brainstem stereotactic biopsy sampling in children.J Neurosurg.2006;104(2 suppl):108–114.
RoujeauT,MachadoG,GarnettMR,et al.Stereotactic biopsy of diffuse pontine lesions in children.J Neurosurg.2007;107(1 suppl):1–4.
TejadaS,AlonsoM,PatiñoA,FueyoJ,Gomez-ManzanoC,Diez-ValleR.Phase I trial of DNX-2401 for diffuse intrinsic pontine glioma newly diagnosed in pediatric patients.开云体育app官方网站下载入口.2018;83(5):1050–1056.
WangZJ,饶L,BhambhaniK,et al.Diffuse intrinsic pontine glioma biopsy: a single institution experience.Pediatr Blood Cancer.2015;62(1):163–165.
WangM,ZhangY,ShiW,ZhuR,LiH,ZhaoR.Frameless robot-assisted stereotactic biopsy: an effective and minimally invasive technique for pediatric diffuse intrinsic pontine gliomas.J Neurooncol.2022;160(1):107–114.
ThomasDG,BradfordR,GillS,DavisCH.有限公司mputer-directed stereotactic biopsy of intrinsic brain stem lesions.Br J Neurosurg.1988;2(2):235–240.
Lo RussoG,MunariC,BettiOO,et al.Stereotactic approach to intracranial lesions.Ital J Neurol Sci.1992;13(1):17–44.
HamischC,KickingerederP,FischerM,SimonT,RugeMI.Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases.J Neurosurg Pediatr.2017;20(3):261–268.
AzarminaM,AzarminaH.The six syndromes of the sixth cranial nerve.J Ophthalmic Vis Res.2013;8(2):160–171.
PugetS,BeccariaK,BlauwblommeT,et al.Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas.Childs Nerv Syst.2015;31(10):1773–1780.
NandiD,AzizTZ,LiuX,SteinJF.Brainstem motor loops in the control of movement.Mov Disord.2002;17(suppl 3):S22–S27.
TejadaS,AquilinaK,GooddenJ,et al.Biopsy in diffuse pontine gliomas: expert neurosurgeon opinion—a survey from the SIOPE brain tumor group.Childs Nerv Syst.2020;36(4):705–711.
MohammadF,WeissmannS,LeblancB,et al.EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.Nat Med.2017;23(4):483–492.
TashiroE,TsuchiyaA,ImotoM.Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.Cancer Sci.2007;98(5):629–635.
VananMI,EisenstatDD.DIPG in children—what can we learn from the past?Front Oncol.2015;5:237.
LouisDN,PerryA,ReifenbergerG,et al.The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.Acta Neuropathol.2016;131(6):803–820.
LuVM,AlviMA,McDonaldKL,DanielsDJ.Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.J Neurosurg Pediatr.2018;23(3):308–316.
LuVM,PowerEA,ZhangL,DanielsDJ.Liquid biopsy for diffuse intrinsic pontine glioma: an update.J Neurosurg Pediatr.2019;24(5):593–600.
ShuiL,RenH,YangX,et al.The era of radiogenomics in precision medicine: an emerging approach to support diagnosis, treatment decisions, and prognostication in oncology.Front Oncol.2021;10:570465.
PugetS,BlauwblommeT,GrillJ.Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma?Am Soc Clin Oncol Educ Book.2012;629-33:629–633.
BenderS,TangY,LindrothAM,et al.Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.Cancer Cell.2013;24(5):660–672.
KeaneL,CherayM,SaidiD,et al.Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas.Neurooncol Adv.2021;3(1):vdab096.
ParkJ,LeeW,YunS,et al.STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma.Oncol Lett.2020;20(2):1989–1998.
LeslieK,LangC,DevganG,et al.Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.Cancer Res.2006;66(5):2544–2552.
DahlNA,DanisE,BalakrishnanI,et al.Super elongation complex as a targetable dependency in diffuse midline glioma.Cell Rep.2020;31(1):107485.
ChiAS,TaraporeRS,HallMD,et al.Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.J Neurooncol.2019;145(1):97–105.
MeelMH,de GooijerMC,Guillén NavarroM,et al.MeLK inhibition in diffuse intrinsic pontine glioma.Clin Cancer Res.2018;24(22):5645–5657.
AmaniV,PrinceEW,AlimovaI,et al.Polo-like kinase 1 as a potential therapeutic target in diffuse intrinsic pontine glioma.BMC Cancer.2016;16(1):647.
YadavilliS,ScafidiJ,BecherOJ,et al.The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.Oncotarget.2015;6(14):12141–12155.
HeissJD,JamshidiA,ShahS,et al.Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.J Neurosurg Pediatr.2018;23(3):333–342.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 590 | 590 | 261 |
Full Text Views | 89 | 89 | 43 |
PDF Downloads | 95 | 95 | 51 |
EPUB Downloads | 0 | 0 | 0 |